Search
Heron Therapeutics Inc
HRTXAdd to Watchlist
0.371USD
+0.078+26.62%
Close 11-09 16:00（ET）
70.43MMarket Cap
LossP/E TTM
After-hours 19:39 (ET)0.380USD+0.013+3.54%
After-hours 19:39 (ET)Heron Therapeutics Inc (HRTX) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Heron Therapeutics Inc in the past month.
Hold
0 Strong Buy
0 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
2.500USD+409.37%
HRTX Analyst Recommendation Trends
In the current month, HRTX has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. HRTX average Analyst price target in the last month is 2.500.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
1
1
3
3
3
3
2
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
3
3
3
3
HRTX Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
IQVIA Holdings Inc
IQV
8
13
1
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, HRTX EPS is projected to reach -0.030 in FY2026Q4, following reported EPS of -0.026 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.01
0.01
-0.03
-0.03
Actual
-0.04
-0.03
-0.03
--
Surprise
-185.13%
-388.40%
+2.89%
--
FAQs
What is Heron Therapeutics Inc's expected revenue for the next quarter?
Heron Therapeutics Inc's expected revenue is 38.40M.
What is Heron Therapeutics Inc's price target?
Analysts forecast that Heron Therapeutics Inc's price target is USD 2.50, with the highest forecast at USD 3.00 and the lowest forecast at USD 2.00.
How have Heron Therapeutics IncHRTX's recent earnings per share performed?
The market expectation was USD -0.03, while Heron Therapeutics IncHRTX's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.03.
What is the analyst rating for Heron Therapeutics Inc?
Based on the ratings of Heron Therapeutics Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.